Li Kang Biomedical Co., Ltd. (TPEX:6242)
35.90
-0.10 (-0.28%)
Jul 17, 2026, 12:53 PM CST
-15.03% (1Y)
| Market Cap | 1.14B -15.0% |
| Revenue (ttm) | 575.98M -0.2% |
| Net Income | 77.56M -4.7% |
| EPS | 2.42 -5.2% |
| Shares Out | 31.81M |
| PE Ratio | 14.83 |
| Forward PE | n/a |
| Dividend | 2.00 (5.57%) |
| Ex-Dividend Date | Jun 16, 2026 |
| Volume | 8,477 |
| Open | 35.50 |
| Previous Close | 36.00 |
| Day's Range | 35.00 - 35.90 |
| 52-Week Range | 35.00 - 43.70 |
| Beta | -0.06 |
| Analysts | n/a |
| Price Target | n/a |
| Earnings Date | Aug 7, 2026 |